DSG Capital Advisors’s Merck MRK Stock Holding History

DSG Capital Advisors’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$236K	Hold	1,958	–	–	0.03%	114
2026 Q1	$236K	Hold	1,958	–	–	0.04%	118
2025 Q4	$217K	Buy	+1,958	New	+$184K	0.03%	116

Other funds holding MRK

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

DSG Capital Advisors's MRK Position: Q2 2026 in Review

DSG Capital Advisors held its Merck (MRK) position steady in Q2 2026 at 1,958 shares worth $236K. The position accounts for 0.03% of the portfolio, ranked #114.

DSG Capital Advisors first reported a position in MRK in Q4 2025 and has held it in 3 quarters since. 3,852 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

DSG Capital Advisors held 1,958 shares of Merck worth $236K as of Q2 2026.
DSG Capital Advisors left its Merck share count unchanged in Q2 2026.
Merck made up 0.03% of DSG Capital Advisors's portfolio in Q2 2026, its #114 holding.
DSG Capital Advisors first reported a position in Merck in Q4 2025 and has held it in 3 quarters since.
3,852 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on DSG Capital Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.